US aesthetic CPQL benchmarks 2026 — verticalized cost-per-qualified-lead across nine treatment categories, three city tiers and four channels
The 2026 Ichelon Consulting US Dallas benchmark set for US aesthetic media — verticalized CPQL bands across botox, laser hair removal, injectables packages, body contouring, plastic surgery, cosmetic dermatology, GLP-1 weight management, hair restoration and skincare retail; CPQL by Tier 1 vs Tier 2 vs Tier 3 metro; CPQL by Meta vs Google vs YouTube vs TikTok; and the seasonal variance pattern and calculation methodology you can defend against a real audit.
- The 2026 US aesthetic CPQL bands, blended across Google Search, Meta, TikTok and YouTube for a US aesthetic practice with compliant creative and qualified-lead rubric: Botox $40-120, laser hair removal $55-180, injectables packages $75-200, body contouring $180-450, plastic surgery consult $120-500, cosmetic derma consult $75-220, GLP-1 weight loss $28-72, hair restoration $120-450, skincare and retail $35-95.
- Tier 1 metros (Manhattan, LA, Miami, SF, Boston) run 2.2x to 3.4x the Tier 3 CPQL baseline. Tier 2 metros (DFW, Houston, Atlanta, Phoenix, Seattle, Chicago, Nashville) sit at 1.4x to 1.8x Tier 3.
- Channel skew: Google Search highest intent, higher CPQL, better consult conversion. Meta lower CPQL on visual offers, wider quality variance. YouTube mid-CPQL, best for AIO capture and educational qualification. TikTok lowest CPQL in metros with under-30 depth, highest quality variance and shortest creative-fatigue cycle.
- Seasonal pattern: Q1 (Jan-Mar) is peak CPQL for injectables (new-year demand); Q2 (Apr-Jun) peak for laser hair and body contouring (spring-summer prep); Q3 (Jul-Sep) trough for laser, peak for cosmetic derma back-to-school; Q4 (Oct-Dec) membership recruitment and gifting drives peak CPQL for retail and injectable series.
- CPBC (cost per booked consultation) runs 2.5x to 4x CPQL depending on funnel maturity, front-desk protocol, and treatment vertical. The lever most operators miss is not the CPQL — it is consult-to-first-treatment conversion, which moves the whole downstream economics.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Why CPQL benchmarks matter in 2026 US aesthetic media
The US aesthetic services economy in 2026 is USD 9.46 billion and growing at 13% compound annual growth rate through 2031 (MarketsAndMarkets). Media spend is one of the two or three largest controllable line items on the P&L of a US medspa, dermatology or plastic surgery practice. And yet, the actual cost-per-qualified-lead a practice is paying — and whether that number is defensible relative to the market — is one of the least-understood numbers in the vertical.
The reason is not that the data is not available. It is that CPQL is a compound number. It is a function of treatment vertical, metro tier, channel mix, creative maturity, landing-page quality, competitive intensity, seasonal window, and the qualifying rubric that decides which lead counts. Two agencies with the same media buy on the same treatment in the same metro can report CPQL numbers that differ by 3x, both technically accurate under different rubrics.
This report gives US practice owners a defensible reference set. The bands are wide because the underlying reality is wide. What matters is not the single number, but the position inside the band that the practice’s specific combination of metro, channel mix, creative maturity and funnel maturity should be at.
The data is a blended synthesis of eighteen-month rolling Ichelon Consulting US-managed US aesthetic media, corroborating publisher benchmarks from ScaleHaven and Orbital 2026 aesthetic sector reports, IBISWorld industry outlooks for medspa and cosmetic services sub-sectors, AmSpa 2026 State of the Industry acquisition-cost sections, and MarketsAndMarkets US Medical Aesthetics 2026-2031 sizing base.
CPQL benchmarks by aesthetic treatment vertical — 2026 US
The table below is the primary benchmark set: cost-per-qualified-lead, cost-per-booked-consultation, typical first-treatment ticket, and the recurring-revenue profile per vertical. Bands are blended across Google Search, Meta, TikTok and YouTube for US markets, exclude branded-search click-through, and assume state medical board-compliant creative.
| Aesthetic vertical | CPQL band (2026) | CPBC band (2026) | Typical first-treatment ticket | Retention pattern |
|---|---|---|---|---|
| Botox / neuromodulator injectables | $40 – $120 | $120 – $420 | $350 – $850 | 12-16 week recurring |
| Laser hair removal (package) | $55 – $180 | $140 – $520 | $650 – $2,200 | 6-8 session package, then annual maintenance |
| Injectables packages (neuromodulator + filler) | $75 – $200 | $220 – $620 | $1,200 – $3,800 | Annual with 2-3 in-between injections |
| Body contouring (cryo, RF, focused ultrasound, muscle-stim) | $180 – $450 | $520 – $1,600 | $1,800 – $6,500 | Series + annual touch-up |
| Plastic surgery consultation | $120 – $500 | $380 – $1,400 | $4,500 – $18,000 (surgical fee) | Typically one-time; revision at 5-10 years |
| Cosmetic dermatology consultation | $75 – $220 | $220 – $640 | $450 – $2,400 (varies by procedure) | Annual for skin cancer + cosmetic maintenance |
| GLP-1 physician-supervised medical weight | $28 – $72 | $95 – $260 | $450 – $1,200/month | Monthly recurring 9-14 months typical |
| Hair restoration (FUE, DHI, PRP, medical) | $120 – $450 | $340 – $1,200 | $3,200 – $14,000 (surgical) / $180-$650 (medical) | Annual maintenance |
| Skincare + cosmeceutical retail | $35 – $95 | $105 – $290 | $150 – $650 initial basket | Membership-driven; 3-6 orders/year |
Why the bands are wide — the five drivers
A CPQL band that runs from USD 40 to USD 120 for Botox in the same country and calendar year is a real reflection of the market, not a hedged estimate. Five drivers stack:
- Metro concentration. Manhattan and Beverly Hills consistently run 2.5x to 3.4x Tier 3 baselines. Miami and San Francisco run 2x to 2.8x. The population-density-adjusted metro CPQL is not linear.
- Platform mix. Search-heavy plans clear at higher CPQL but higher CPBC quality; social-heavy plans invert. Blended CPQL depends on the mix.
- Creative maturity. A stale creative on Meta triples CPQL within two weeks. Practices with a mature creative-refresh cadence sit at the bottom of the band; practices that let creative age sit at the top.
- Landing-page quality. A page built for the specific treatment converts four to seven times better than a homepage. CPQL on the same media buy differs by 3x-5x depending on the destination page.
- Competitive intensity. A metro with a franchise brand actively bidding often lifts everyone’s CPQL by 20-35% on relevant queries.
CPQL by US city tier — Tier 1, Tier 2, Tier 3
Metro tier is the single largest structural driver of CPQL after treatment vertical. The tiers below are the working definition Ichelon Consulting US uses for US aesthetic media planning; they are not census brackets but demand-concentration brackets.
Tier definition
- Tier 1 — Prime aesthetic metros: Manhattan, Los Angeles, Miami, San Francisco, Boston. Highest aesthetic ad-competitor concentration, highest CPQL, highest per-capita LTV. Also the highest per-metro absolute lead volume ceiling.
- Tier 2 — Anchor aesthetic metros: Dallas-Fort Worth, Houston, Atlanta, Phoenix-Scottsdale, Seattle, Chicago, Nashville, Denver, Charlotte, Washington DC. Strong aesthetic base with real ad-competitor density; CPQL sits at 1.4x-1.8x Tier 3 baseline.
- Tier 3 — Secondary and tertiary metros: Metros below 1M population and secondary regional centers. Lower CPQL, lower absolute lead volume, but also lower LTV in most treatment verticals except GLP-1 where the LTV-to-metro correlation is weaker.
| Aesthetic vertical | Tier 1 metro CPQL | Tier 2 metro CPQL | Tier 3 metro CPQL |
|---|---|---|---|
| Botox / neuromodulator | $95 – $180 | $55 – $110 | $40 – $70 |
| Laser hair removal | $140 – $260 | $80 – $150 | $55 – $95 |
| Injectables packages | $180 – $340 | $110 – $210 | $75 – $140 |
| Body contouring | $380 – $720 | $240 – $460 | $180 – $320 |
| Plastic surgery consult | $320 – $700 | $180 – $380 | $120 – $260 |
| Cosmetic derma consult | $180 – $320 | $110 – $210 | $75 – $140 |
| GLP-1 weight management | $55 – $95 | $34 – $60 | $28 – $48 |
| Hair restoration | $320 – $650 | $180 – $340 | $120 – $240 |
| Skincare + retail | $75 – $140 | $45 – $85 | $35 – $65 |
Why Manhattan and LA break the pattern
Manhattan and Los Angeles are Tier 1 metros with a specific structural characteristic that pushes CPQL higher than the tier baseline: aesthetic-agency density combined with brand-name national franchise bidding. A Manhattan medspa is competing not just with neighboring practices but with several national aesthetic brands bidding aggressively on the same Google auction. LA has the same structure with a wider geographic footprint. The 2.5x-3.4x Tier 3 multiple reflects that stacked competitive intensity, not just population density.
Why Salt Lake City breaks a different pattern
Salt Lake City is a nominal Tier 3 metro that behaves like a Tier 2 metro in dermatology CPQL specifically because it is the highest-density dermatology practice metro over 1 million population in the US, per WebMD directory analysis. High local practice density lifts CPQL toward Tier 2 territory on dermatology-specific queries even where general aesthetic CPQL sits at Tier 3.
CPQL by channel — Google Search vs Meta vs YouTube vs TikTok
Channel is the second-largest structural driver of CPQL after metro tier. Each channel produces a distinct CPQL profile and a distinct downstream quality profile. The right question is not “which channel is cheaper” but “which channel produces the CPBC and first-treatment revenue this practice needs.”
| Channel | CPQL characteristic | Downstream conversion characteristic | Fit for |
|---|---|---|---|
| Google Search (branded + non-branded) | Higher CPQL — typical mid-band | Highest CPBC quality; near-me intent captures booking | Every aesthetic vertical; foundational allocation 30-40% |
| Google Business Profile (organic + $) | Effectively zero incremental CPQL for organic | Highest ROI hour of the week; strong consult conversion | Every US aesthetic practice, non-negotiable |
| Meta Ads (Facebook + Instagram) | Lower CPQL on visual offers; wide quality variance | Segment 2 event-driven trial; strong membership recruitment | Visual verticals: laser hair, body contouring, injectables trials |
| YouTube Ads | Mid CPQL; AIO capture layer | Educational qualification; long consideration cycle procedures | Plastic surgery, hair restoration, body contouring |
| TikTok Ads | Lowest CPQL in under-30-depth metros; short creative-fatigue cycle | Trial acquisition; Segment 2 conversion; not for maintenance | Metros with dense under-30 demographic; not every market |
| Programmatic display & retargeting | Retention-window CPQL; not a primary acquisition lever | Retargeting recovers 18-32% of considered-but-lapsed intent | Retention layer, not front of funnel |
| Email & SMS (owned) | Owned channel — zero acquisition CPQL | Highest-margin channel; retention revenue engine | Every practice with an established customer base |
Google Search vs Meta — the honest comparison
The most-common single question in a US aesthetic media planning conversation is whether to lean Google Search or Meta. The honest answer is that the two channels produce different customers on different economic terms, and the right allocation depends on the practice’s current customer mix and the treatment ladder they are trying to build.
Google Search captures near-term intent — the customer who has decided to search for a Botox appointment near me is already at the bottom of the funnel. CPQL is higher, CPBC quality is higher, and consult-to-first-treatment conversion is meaningfully better. This is the channel that fills chairs in the next four to eight weeks.
Meta captures event-driven trial — the customer who saw a well-crafted before/after or a member testimonial and decided to enquire. CPQL is lower, CPBC quality is more variable, and the consult-to-first-treatment cycle is longer. But Meta is also where net-new Segment 2 customer volume comes from, which is what a growth thesis actually needs.
The 2026 US aesthetic industry pattern for a growth-oriented practice is roughly 35% Google Search, 30% Meta, 15% YouTube, 10% TikTok (metro-dependent), 10% programmatic and retention. Owned channels sit outside that allocation on the retention side.
YouTube as the AIO capture layer
YouTube Ads in 2026 do something distinctive in aesthetic marketing: they educate a considered-purchase customer through the qualification funnel while simultaneously feeding the AI Overview citation layer on the same treatment queries. A well-produced physician-led educational video, ranked on YouTube for a specific procedure question, is now cited in Google AI Overviews on the same query in a meaningful minority of cases. The Ichelon Consulting US YODA product is built around that convergence.
TikTok metro fit
TikTok Ads are the lowest-CPQL channel in metros with dense under-30 demographic bases — New York, Los Angeles, Miami, Austin, Nashville, Atlanta — and a poor fit in metros without that demographic depth. TikTok creative also fatigues fastest of any channel in the mix; a two-week creative-refresh cadence is the baseline, and a one-week cadence is preferable during peak seasonal windows.
Seasonal variance in US aesthetic CPQL through the calendar year
US aesthetic CPQL is not a flat number across the calendar year. Every treatment vertical has a seasonal pattern that shifts CPQL by 20-45% between peak and trough, and every media plan should be sized against the seasonal profile of the practice’s treatment mix.
| Vertical | Q1 (Jan-Mar) CPQL move | Q2 (Apr-Jun) CPQL move | Q3 (Jul-Sep) CPQL move | Q4 (Oct-Dec) CPQL move |
|---|---|---|---|---|
| Botox / neuromodulator | +18-32% (new-year peak) | Baseline | −8-12% (summer trough) | +12-22% (year-end + gift) |
| Laser hair removal | −10-18% (winter trough) | +22-38% (spring peak) | +8-14% (late-summer maintenance) | −14-22% (Q4 trough) |
| Injectables packages | +15-28% (new-year) | +8-14% (spring event) | Baseline | +18-30% (Q4 gift + prep) |
| Body contouring | +22-38% (new-year resolution peak) | +14-24% (summer prep) | −12-18% (summer trough) | Baseline |
| Plastic surgery consult | +14-22% (new-year) | Baseline | −8-14% (school-year trough) | +10-18% (year-end) |
| Cosmetic derma consult | Baseline | +10-18% (spring skin) | +8-14% (back-to-school peak) | Baseline |
| GLP-1 weight management | +30-45% (new-year peak) | +8-14% (summer prep) | −10-14% (summer) | +18-28% (Q4 rebound) |
| Hair restoration | +18-28% (new-year) | Baseline | −10-14% (summer holiday) | +8-14% (year-end) |
| Skincare + retail | +8-14% (new-year) | Baseline | Baseline | +35-58% (Q4 gifting peak) |
Q1 — the new-year peak
Q1 is peak CPQL for four of the nine verticals: Botox, injectables packages, body contouring and GLP-1. All four are driven by the same underlying behavioral trigger — the new-year decision to invest in an aesthetic outcome. GLP-1 sees the sharpest Q1 lift (30-45% above baseline) because the weight-management category benefits from the strongest new-year resolution behavior. Body contouring sees a similar lift for the same reason.
The tactical implication is that Q1 media budgets should be planned at 130-145% of average-quarter spend, with acceptance that CPQL will run above the annual band. The alternative — running at annual-average budget in Q1 — leaves acquisition volume on the table because the demand exists at inflated CPQL and disappears in Q2.
Q2 — the spring-summer prep window
Q2 is peak CPQL for laser hair removal (22-38% lift) and second-peak for injectables and body contouring driven by spring event and summer prep. The Q2 CPQL lift is more concentrated than the Q1 lift — roughly six weeks of intense demand in April and May, tapering into June. Media plans should front-load Q2 spend into the April-May window.
Q3 — the summer trough (for some verticals)
Q3 is a mixed picture. Injectable and body contouring demand softens (family holidays, competitive activity, patient absence). Cosmetic dermatology actually peaks in Q3 driven by back-to-school skin-visit patterns. GLP-1 dips modestly. The right Q3 plan is a treatment-mix rebalance rather than a blanket reduction.
Q4 — the year-end and gifting peak
Q4 is the second peak of the year, driven by gift-card revenue, membership recruitment, year-end aesthetic prep for holidays and events, and use-it-or-lose-it insurance and HSA balance dynamics. Skincare and retail see a 35-58% lift in November-December that dominates the annual retail revenue mix.
What we found when we studied 555 US med spas on Google
Patients praise the care almost without exception. The one area where complaints outnumber praise is booking and communication, and that is where most med spas can win.
Full study · 555 US med spas across 20 metros · roughly ±4% nationally · review velocity and themes from a 115-spa subsample · verified against raw data.
CPQL calculation methodology — what actually counts as a qualified lead
CPQL is only useful if the definition of a “qualified lead” is honest and consistent. The 2026 Ichelon Consulting US aesthetic CPQL definition is documented in writing for every engagement and reviewed quarterly. The definition below is the reference set this report’s benchmarks were calculated against.
The qualified-lead rubric — six inclusion criteria
- Criterion 1 · Contactable identity. Lead has a valid phone number or a valid, deliverable email address. Unreachable submissions do not count as qualified leads.
- Criterion 2 · Geographic fit. Lead is in the practice’s catchment area or in a defensible catchment for a specific treatment vertical. Out-of-area leads are logged separately and excluded from CPQL denominator unless the practice specifically wants to run destination-aesthetic acquisition.
- Criterion 3 · Treatment-intent fit. Lead expressed intent for a treatment the practice actually delivers. Enquiries for services the practice does not offer are logged and excluded.
- Criterion 4 · De-duplication. Same identifier (phone or email) submitting through multiple channels within 30 days counts as one qualified lead attributed to first-touch, not per submission.
- Criterion 5 · Non-competitor identity. Submissions identified as competitor-agency research, vendor sales prospecting or personal-network enquiries are excluded.
- Criterion 6 · Consent capture. Lead completed a compliant consent capture (HIPAA authorization for follow-up communication, TCPA prior express written consent where SMS follow-up is planned). Absent consent, the lead cannot be worked and does not count.
Attribution model — first-touch, position-based, or data-driven
Ichelon Consulting US aesthetic reporting uses a position-based attribution model by default: 40% of credit to first-touch, 40% to last-touch, 20% distributed across intermediate touches. This is the closest available approximation of what actually happens in the customer’s decision journey for a considered aesthetic purchase. The alternative models are:
- First-touch attribution. Overweights top-of-funnel channels (Meta, YouTube) and understates the closing role of Google Search. Not recommended as sole model.
- Last-touch attribution. Overweights bottom-of-funnel channels (Google Search, direct, referral) and understates top-of-funnel discovery. Not recommended as sole model.
- Linear attribution. Distributes credit evenly across touches. Simple but does not reflect the disproportionate weight of first and last touches in an aesthetic decision journey.
- Data-driven attribution. Machine-learned per-touch weights. Requires sufficient conversion volume (typically 400+ conversions per 30-day window) to be reliable; most single-location US aesthetic practices do not reach that threshold.
Cost inclusions and exclusions
The CPQL numerator is total media spend across the measurement window, inclusive of platform-fee reserves, click waste (bot filtering, duplicate clicks), and any spend on retargeting attributed to the lead source. It is exclusive of retainer fees (retainer is amortized separately in the CAC calculation), of content-production costs (amortized across expected content life), and of tooling costs (amortized across expected utility life).
CPBC and consult-to-first-treatment — the numbers that matter more
The failure mode inside most US aesthetic growth plans is not the CPQL number. It is the ratio of CPQL to CPBC and the consult-to-first-treatment conversion. A well-run injectable program should convert booked consultations to first treatments at 55-72%. A well-run body-contouring program runs 32-48%. The lever that moves both is not the media buy — it is the consult protocol, price presentation and follow-up sequence.
Consult conversion by vertical (2026)
Injectables 55-72% · Laser hair 62-78% · Body contouring 32-48% · Plastic surgery 26-42% · Cosmetic derma 48-62% · GLP-1 45-64% · Hair restoration 32-46% · Skincare retail (upsell) 24-38%.
What moves consult conversion
Structured consult template, price-anchored proposal, in-consult financing offer, same-week follow-up sequence, physician-time-in-consult standard. Practices that fix these four levers see a 12-18 percentage-point lift on injectables and 8-14 on body contouring.
What does NOT move consult conversion
More media spend, more channels, more creative variants, more Google keywords. All of these change CPQL, not consult conversion. Order of operations matters: fix conversion, then scale spend.
The follow-up sequence
Same-day text plus email plus voicemail; 24-hour follow-up if not booked; 72-hour and 7-day sequence with progressive incentive. Practices with mature follow-up see 22-38% more bookings from the same lead pool.
Compliance envelope — the CPQL cost of getting the rules wrong
The CPQL bands published in this report assume state medical board-compliant creative and HIPAA-safe measurement. Non-compliant creative frequently produces lower headline CPQL — because compliance friction is genuinely a cost — but the downstream compliance cost is meaningful. A single state medical board advertising complaint typically consumes 40-80 hours of practice-owner and legal time, at a fully-loaded cost that dwarfs the media savings.
State medical board CPQL implication
State medical board rules do not directly move CPQL. They constrain what creative is legal, which indirectly moves CPQL because compliant creative typically converts differently than non-compliant creative. A superlative claim (“best in the region”) that Texas permits with substantiation, California treats as presumptively false under B&P Code §651. A landing page that runs a superlative headline in Texas may need a different headline for California, and the CPQL on the California variant will differ.
Ten-state advertising rule matrix
| State | Advertising rule anchor | CPQL implication |
|---|---|---|
| California | B&P Code §651 | Strict superlative rule; more creative iteration; CPQL trends higher |
| Texas | Texas Medical Board Chapter 164 | Before/after and testimonial rules require dedicated creative variants |
| Florida | Board of Medicine cosmetic-advertising rules | Warning language required on before/after; ad approval friction adds to CPQL |
| New York | NY Public Health Law §238; CPOM | Fee-disclosure rules; testimonial-adjacent scrutiny; entity naming implications |
| Georgia | Composite Medical Board rules | Provider-credential disclosure adds creative complexity |
| Arizona | ARS §32-1401, §32-1454 | Physician-of-record disclosure requirements; medspa-specific creative rules |
| Tennessee | Tennessee Board of Medical Examiners | Scope-reflection rule; APRN collaboration disclosure |
| Illinois | Illinois Medical Practice Act §22 | Qualifications-disclosure rule; entity-naming rules |
| Washington | WAC 246-919 | Strict testimonial and superlative rules; requires state-specific variants |
| Massachusetts | 243 CMR 2.07 | CPOM enforcement; specific advertising disclosure |
The US practice base
Ichelon Consulting US operates from Dallas, TX — inside the #1 US state for medspa density — and serves multi-market aesthetic clients across Texas, California, Florida, New York, Georgia, Arizona, Tennessee, Illinois, Washington and Massachusetts. Every media engagement is HIPAA-scoped under a signed BAA, state medical board-vetted, and CPQL-benchmarked against the ranges published in this report.
Backed by ICG global leadership
Every US aesthetic engagement has direct line-of-sight to the Ichelon Consulting US Leadership Team and a senior reviewer with scaled experience in US medspa, derma and plastic surgery growth, media planning, compliance and multi-market rollup dynamics.
Our own tools run inside every engagement
Ichelon Consulting US uses software built by our own product team. Practices can also use most tools on their own, billed in USD.
US aesthetic CPQL benchmarks — common questions
What is the average CPQL for Botox marketing in the United States in 2026?
USD 40 to USD 120 blended across Google Search, Meta, TikTok and YouTube. Tier 1 metros (Manhattan, LA, Miami, SF, Boston) at the top of the band. Tier 3 metros at the lower end. CPBC is typically 2.5x-3.5x CPQL.
What is the average CPQL for laser hair removal in the US in 2026?
USD 55 to USD 180 blended. Meta typically produces the lower half; Google Search the top. CPBC is 2x-3x CPQL because consultation conversion is above average.
What is the average CPQL for injectables packages in the US in 2026?
USD 75 to USD 200 blended for neuromodulator plus dermal filler packages. Higher than single-service Botox because ticket is higher and rubric is stricter.
What is the average CPQL for body contouring in the US in 2026?
USD 180 to USD 450 blended. Runs at the top of aesthetic CPQL because consideration cycle is longer and rubric is stricter. CPBC is USD 520 to USD 1,600.
What is the average CPQL for plastic surgery consultations in the US in 2026?
USD 120 to USD 500 blended. Rhinoplasty and breast augmentation at the top; skin-only procedures at the lower end. CPBC is USD 380 to USD 1,400.
What is the average CPQL for cosmetic dermatology consultations in the US in 2026?
USD 75 to USD 220 blended. Between medspa injectable CPQL and plastic surgery CPQL. CPBC is USD 220 to USD 640.
What is the average CPQL for GLP-1 medical weight loss in the US in 2026?
USD 28 to USD 72 blended — the lowest CPQL in the aesthetic-adjacent stack. Trap is qualification: raw volume converts poorly to first-treatment unless CRM filters aggressively.
What is the average CPQL for hair restoration in the US in 2026?
USD 120 to USD 450 blended. Surgical FUE and DHI at the top; medical hair management (finasteride, minoxidil, oral) at the lower end.
What is the average CPQL for skincare and cosmeceutical retail in the US in 2026?
USD 35 to USD 95 blended. Low CPQL but low LTV per acquired customer unless retail integrates with membership program.
How does CPQL vary between US Tier 1 metros and secondary metros?
Tier 1 vs Tier 3 delta is 2.2x-3.4x on the same treatment vertical. Tier 2 sits at 1.4x-1.8x Tier 3. Salt Lake City behaves like Tier 2 in dermatology specifically due to highest metro-over-1M derma density.
Scope a US aesthetic media engagement with Ichelon Consulting US
Book a 30-minute call with a member of the Leadership Team, email the US practice lead in Dallas, or reach us by phone. Every engagement starts with a signed BAA and a defensible CPQL rubric benchmarked against the ranges published in this report.
Continue the US aesthetic stack
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
Key findings
- The 2026 allocation pattern for a growth-oriented US aesthetic practice is roughly 35% Google Search, 30% Meta, 15% YouTube, 10% short-video social and 10% programmatic and retention.
- Google Search delivers the highest intent and the best consult conversion; Meta works best on visual offers but with wider lead-quality variance.
- Injectables and body contouring peak in Q1 on new-year demand; laser hair removal peaks in Q2; cosmetic dermatology peaks in Q3 with back-to-school skin visits.
- Q4 is the second peak of the year, driven by gift cards, membership recruitment and year-end HSA balances, with skincare and retail dominating November-December.
- The lever most operators miss is consult-to-first-treatment conversion, which moves the whole downstream economics more than lead cost does.
How to cite this report
US Aesthetic CPQL Benchmarks 2026, Ichelon Consulting Group, 2026. https://ichelonconsulting.com/us-aesthetic-cpql-benchmarks-2026
Free to quote and reuse with attribution and a link to this page.
Related research
Questions this report answers
How should a US aesthetic practice split its media budget?
Ichelon Consulting US's 2026 aesthetic benchmark, built on two years of US aesthetic media it manages, describes a typical growth mix of about 35% Google Search, 30% Meta, 15% YouTube, 10% short-video social and 10% programmatic and retention, adjusted by metro.
When is demand highest for med spa and aesthetic treatments?
It depends on the treatment. The benchmark finds injectables and body contouring peak in Q1, laser hair removal in Q2, cosmetic dermatology in Q3 around back-to-school, and Q4 is a second peak driven by gift cards, memberships and year-end HSA balances.
Is Google or Meta better for aesthetic practice leads?
They produce different customers. The report finds Google Search brings the highest intent and best consult conversion, while Meta performs on visual offers with wider quality variance. The right split depends on the practice's treatment ladder and current patient mix.
What is the most overlooked metric for aesthetic practices?
Consult-to-first-treatment conversion. The benchmark argues this moves the practice's downstream economics more than lead cost does, and depends on front-desk protocol and funnel maturity as much as on media. It draws on two years of managed US aesthetic media.